Gilead Announced Results from Phase III Trial of Remdesivir On June 01, 2020, Gilead made and announcement, through a press release, about the results from its phase III SIMPLE trial of remdesivir in human patients.
Host Factor Determines the Severity of COVID-19, not the Varied Strain Researchers analyzed the clinical, molecular, and immunological data from 326 confirmed cases of COVID-19 in Shanghai and discovered two different SARS-CoV-2 strains within their patient cohort but that viral variations did not significantly affect the patient outcomes.
Adding a Nylon Stocking Really Improves Filtering Efficiency of Homemade Cloth Masks Researchers claimed that the filtration ability of homemade masks was lower than 30% (in normal) but when they are added with the pantyhose layer, their filtration ability boosts anywhere from 15% to 50%.
Here is the Most Detailed 3D Representation of SARS-COV-2 The coronavirus RNA molecule is one of the largest amongst all RNA viruses at 30,000 'letters' long, which is about twice the size of the influenza A genome, but still 100,000 times smaller than the human genome (over 3 billion 'letters' long).
Yes, Coronavirus is Mutating but You don’t Need to Panic Researchers have identified 6,822 mutations of SARS-CoV-2 across a global dataset among which 273 mutations have occurred repeatedly and independently.
Another COVID-19 Vaccine Enter in Phase 1/2 of Clinical Trial The Clinical trial started on May 25, 2020. First volunteer participants are already enrolled. Estimated Primary Completion Date is December 31, 2020, and Estimated Study Completion Date July 31, 2021.
A Prominent Technique to Detect SARS-CoV-2: Real Time RT-PCR(rRT-PCR) Real-time RT-PCR has risen to become the benchmark technology for the detection and/or comparison of RNA levels for several reasons...
Researchers from Harvard and MIT are Working Together to Develop a Face Mask that can Light up When it Detect Coronavirus For the fast, easier and safe detection of coronavirus, researchers James Collins, Peter Nguyen, and Nina Donghia, and Luis Soenksen at the Wyss Institute are developing a rapid self-activating COVID-19 diagnostic face mask which can detect coronavirus when an affected person wears it.
Phase II/III of COVID-19 Vaccine is About to Begin at Oxford COVID-19 Vaccine Centre The University of Oxford, Oxford COVID-19 Vaccine Centre's researchers have already begun recruiting human volunteers for the next phase in human trials of a COVID-19 vaccine trial in humans.
COVID-19: Another Potent Antiviral Drug in the List A team of researchers has recently found that an antiviral drug can help speed up the recovery of COVID-19 patients. The international team was led by Dr. Eleanor Fish, Scientist Emeritus at the Toronto General Hospital Research Institute, University Health Network (UHN), and professor at the University of Toronto's Department of Immunology.